Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Head & Neck 1Genitourinary 1

Conditions

Head and Neck Neoplasms 193Squamous Cell Carcinoma of Head and Neck 171Oropharyngeal Neoplasms 35Carcinoma, Squamous Cell 26Nasopharyngeal Carcinoma 24Laryngeal Neoplasms 21Mouth Neoplasms 20Radiation Injuries 15Nasopharyngeal Neoplasms 12Hypopharyngeal Neoplasms 12Salivary Gland Neoplasms 11Xerostomia 8Neoplasms 8Mucositis 7Laryngeal Diseases 7Tongue Neoplasms 6Esthesioneuroblastoma, Olfactory 6Carcinoma, Non-Small-Cell Lung 6Carcinoma 6Thyroid Neoplasms 5Lung Neoplasms 5Recurrence 4Prostatic Neoplasms 4Melanoma 4Breast Neoplasms 4Thyroid Carcinoma, Anaplastic 3Rectal Neoplasms 3Pharyngeal Neoplasms 3Paranasal Sinus Neoplasms 3Pancreatic Neoplasms 3

Interventions

Dexamethasone 3fosaprepitant 2Palonosetron 2Aprepitant 2Tropisetron 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Ondansetron 1Olanzapine 1Electroacupuncture 1Cisplatin 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vomiting × Radiotherapy × Head & Neck × Clear all
NCT00895245 2017-05-18

Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy

University of Washington

Phase 2 Terminated
6 enrolled 5 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡